|
|
|
|
 |
|
SENSEX
|
 |
-427.14
|
-0.59%
|
|
71599.01
|
|
|
|
NIFTY
|
|
-128.35
|
-0.59%
|
|
21582.45
|
|
|
|
Nasdaq
|
 |
13.77
|
0.09%
|
|
14524.07
|
|
|
|
Nikkei 225
|
|
89.13
|
0.27%
|
|
33377.42
|
|
|
|
FTSE 100
|
|
-33.50
|
-0.43%
|
|
7689.60
|
|
|
 |
|
|
|
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
04-01-2024
|
|
|
|
| With reference to the Postal Ballot Notice dated December 1, 2023, following resolutions have been approved with requisite majority through e-voting:a) Divestment proposal of the Fortis Malar Hospital and transactions in relation thereto to be entered int |
|
|
|
|
|
04-01-2024
|
|
|
|
| With reference to the Postal Ballot Notice dated December 1, 2023, following resolutions have been approved with requisite majority through e-voting:a) Divestment proposal of the Fortis Malar Hospital and transactions in relation thereto to be entered into by Fortis Malar Hospitals Limited (FMHL), an Indirect/step down subsidiary of the Company (Special Resolution).b) Divestment proposal of the Fortis Malar Hospital and transactions in relation thereto to be entered into by Fortis Health Management Limited (FHML), a subsidiary of the Company (Special Resolution).c) Divestment proposal of the Fortis Malar Hospital and transactions in relation thereto to be entered into by Hospitalia Eastern Private Limited (HEPL), a step-down subsidiary of the Company (Special Resolution).d) Appointment of Dr. Prem Kumar Nair (DIN: 10348774) as a Non-Executive Director of the Company (Ordinary Resolution).Please find enclosed Scrutinizer s Report along with result of postal ballot in prescribed format.This is for your information and records. |
|
|
|
|
|
03-01-2024
|
|
|
|
| With reference to the Postal Ballot Notice dated December 1, 2023, following resolutions have been approved with requisite majority through e-voting:a) Divestment proposal of the Fortis Malar Hospital and transactions in relation thereto to be entered into by Fortis Malar Hospitals Limited (FMHL), an Indirect/step down subsidiary of the Company (Special Resolution).b) Divestment proposal of the Fortis Malar Hospital and transactions in relation thereto to be entered into by Fortis Health Management Limited (FHML), a subsidiary of the Company (Special Resolution).c) Divestment proposal of the Fortis Malar Hospital and transactions in relation thereto to be entered into by Hospitalia Eastern Private Limited (HEPL), a step-down subsidiary of the Company (Special Resolution).d) Appointment of Dr. Prem Kumar Nair (DIN: 10348774) as a Non-Executive Director of the Company (Ordinary Resolution).Please find enclosed Scrutinizer s Report along with result of postal ballot in prescribed format.This is for your information and records. |
|
|
|
|
|
29-12-2023
|
|
|
|
| The Company is in receipt of an email dated 27th December 2023 from BSE Limited, whereinit has been stated, that .the Company was obligated to disclose the Interim Award and thesubsequent material developments (regarding termination of the Interim Award |
|
|
|
|
|
28-12-2023
|
|
|
|
| Fortis Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
|
|
|
|
|
28-12-2023
|
|
|
|
| FORTIS HEALTHCARE LIMITED has informed the Exchange about Closure of Trading Window |
|
|
|
|
|
28-12-2023
|
|
|
|
| The Company is in receipt of an email dated 27th December 2023 from BSE Limited, whereinit has been stated, that .the Company was obligated to disclose the Interim Award and thesubsequent material developments (regarding termination of the Interim Award and filing ofthe suit before the Hon ble High Court of Delhi) to comply with Regulations 30(3) and (7) readwith Regulations 30(4)(i)(a) and (b) and Clause 8 of Para B of Part A of Schedule III of theSEBI (LODR) Regulations and instructed to submit detailed disclosure latest by December28, 2023. A detailed disclosure is enclosed. |
|
|
|
|
|
27-12-2023
|
|
|
|
| Fortis Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
|
|
|
|
|
27-12-2023
|
|
|
|
| FORTIS HEALTHCARE LIMITED has informed the Exchange about Closure of Trading Window |
|
|
|
|
|
27-12-2023
|
|
|
|
| In terms of Regulation 30(4) of SEBI Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 and reference to our letter dated November 14, 2023 regarding a material litigation filed by Northern TK Venture Pte Ltd., the Promoter shareholder of the Company ( NTK ), against Daiichi Sankyo Company, Limited before the Tokyo District Court in Japan.In furtherance to the aforesaid announcement, a copy of the announcement released by IHH Parent Company of NTK, to the Bursa, Malaysia and Singapore Stock Exchanges is enclosed herewith. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|